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Psychiatric disorders are a group of human diseases that impair higher cognitive
functions. Whole-genomic analyses have recently identified susceptibility genes for
several psychiatric disorders, including schizophrenia. Among the genes reported to be
involved in psychiatric disorders, a gene encoding a polysialyltransferase involved in the
biosynthesis of polysialic acid (polySia or PSA) on cell surfaces has attracted attention for
its potential role in emotion, learning, memory, circadian rhythm, and behaviors. PolySia is
a unique polymer that spatio-temporally modifies neural cell adhesion molecule (NCAM)
and is predominantly found in embryonic brains, although it persists in areas of the adult
brain where neural plasticity, remodeling of neural connections, or neural generation is
ongoing, such as the hippocampus, subventricular zone (SVZ), thalamus, prefrontal cortex,
and amygdala. PolySia is thought to be involved in the regulation of cell-cell interactions;
however, recent evidence suggests that it is also involved in the functional regulation of
ion channels and neurologically activemolecules, such as Brain-derived neurotrophic factor
(BDNF), FGF2, and dopamine (DA) that are deeply involved in psychiatric disorders. In this
review, the possible involvement of polysialyltransferase (ST8SIA2/ST8SiaII/STX/Siat8B)
and its enzymatic product, polySia, in schizophrenia is discussed.
Keywords: schizophrenia, psychiatric disorder, polysialic acid, polysialyltransferase, ST8SIA2, NCAM, BDNF,
dopamine
INTRODUCTION
Schizophrenia is a severe and persistent psychiatric disorder
that affects approximately one percent of the population world-
wide. Although several factors are associated with an increased
risk of developing schizophrenia, the underlying mechanism for
this disorder remains unclear. The overall risk profile is mainly
determined by the presence of causative genes, such as those
encoding disrupted-in-schizophrenia 1 (DISC1) (Millar et al.,
2001), Neuregulin 1 (Stefansson et al., 2002), COMP (catechol-
o-methyltransferase) (Strous et al., 1997), and dopamine (DA)-
receptors (Allen et al., 2008). Schizophrenia is also deeply related
to neurodevelopmental and neurodegenerative diseases involv-
ing disconnectivity and disorder of synapses (Woods, 1998;
Ashe et al., 2001), which may occur at a restricted stage dur-
ing early brain development. Despite the identification of these
schizophrenia risk factors, studies investigating the specific rela-
tionships between genes and phenotypes are needed. In this
regard, the contribution of the posttranslational modification of
proteins and the presence of membrane glycans, such as glycopro-
teins, gangliosides, and proteoglycans, are important to consider.
However, these factors are often overlooked, even though nearly
all cell-surface and extracellular proteins are glycosylated.
Animal cells are covered by the glycocalyx, a dense sugar coat
composed of glycoproteins, glycolipids, and proteoglycans that
provide hot spots for interaction with other cells and extracellular
space components. The glycocalyx has a unique and character-
istic structure, particularly in the peripheral region, which is
the dominant region for communication with other cells and
extracellular factors. Among glycans in the glycocalyx, polysialic
acid (polySia, PSA), HNK-1, and sulfated glycans share spatio-
temporally regulated expression. In particular, polySia is of con-
siderable recent interest in the field of schizophrenia research,
and has been studied using histochemical, genome-wide, and
biochemical approaches.
In this review, we describe: (1) the unique features of polySia
and its biosynthesis enzyme, ST8SIA2; (2) the newly discovered
functions of polySia; and (3) the relationship between polySia and
psychiatric disorders, particularly schizophrenia, which have been
reported to date.
STRUCTURE AND DISTRIBUTION OF polySia AND ST8SIA2
PolySia is a linear homopolymer of sialic acid with a degree of
polymerization (DP) ranging from 8 to 400 (Figure 1A) (Troy,
1996) and was first found as part of polysaccharide chains on the
cell surface of neuroinvasive bacteria. PolySia is thought to adopt
a helical structure (Evans et al., 1995) (Figure 1B) and can be
identified with specific probes, such as antibodies (mAb. 735 and
mAb. 12E3) and endo-N-acylneuraminidase (Endo-N) (Troy,
1996; Rutishauser, 2008; Sato, 2013). The expression of polySia
in vertebrates is spacio-temporally regulated (Rutishauser, 2008)
and is highly restricted to the brain during embryonic and post-
neonatal development. In the adult brain, polySia is typically
found at very low levels; however, it persists in distinct regions
where neural plasticity, remodeling of neural connections, or neu-
ral generation is ongoing, such as the hippocampus, subventric-
ular zone (SVZ), thalamus, prefrontal cortex, and amygdala. It is
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FIGURE 1 | Structures of polySia, polySia-NCAM, and polySia-synCAM.
(A) α2-8linked polySia structure. R = -NHCOCH3, Neu5Ac; -NHCOCH2OH,
Neu5Gc, -OH, KDN. In the brain, polySia is polyNeu5Ac. (B) Molecular
modeling of polySia (DP = 12). The polySia structure is linked to Gal at the
C3-position. Calculated α2,8-linked dodecaNeu5Ac-Gal structure is shown as
space-filling models. The MOE program was used for the construction and
calculation of the energies of α2,8-linked polySia. (C) polySia-NCAM-180 and
polySia-synCAM-1. Left panel, NCAM-180. NCAM has five immunoglobulin
domains (IgI∼IgV) and two fibronectin type-III (FNIII ) domains in its
extracellular domain. In the IgV domain, two of the three N-glycosylation
sites (triangle) are polysialylated and are indicated by black circles (sialic acid).
Right panel, SynCAM-1. SynCAM-1 has three Ig domains. In the IgI domain,
one of the three N-glycosylation sites (triangle) is occupied by polySia which
is indicated by black circles (sialic acid).
also interesting that polySia expression is restricted to interneu-
rons in different cortical regions, such as the prefrontal cortex
and amygdala (Gómez-Climent et al., 2011; Nacher et al., 2013).
There are several precise reviews on polySia and polysialylated
NCAM (polySia-NCAM) expression in brains (Bonfanti, 2006;
Nacher et al., 2013; Sato, 2013). The major carrier protein of
polySia in vertebrate brains is neural cell adhesion molecule
(NCAM) (Finne et al., 1983). As NCAM expression levels remain
relatively unchanged throughout normal development, it is spec-
ulated that polySia expression is tightly correlated with that
of the polySia biosynthetic enzymes, particularly the polysialyl-
transferases ST8SIA2 and/or ST8SIA4 (Mühlenhoff et al., 2009).
Recently, ST8SIA2 was also demonstrated to modify synaptic
cell adhesion molecule 1 (synCAM-1) (also known as Cadm1 or
TSLC1) (Rollenhagen et al., 2012). The polysialylation sites on
NCAM and synCAM have been well studied. NCAM consists of
five immunoglobulin (Ig)-like domains with six N-glycosylation
sites and two fibronectin type-III (FNIII)-like -domains in the
extracellular region. PolySia chains are linked to the tri- or tetra-
antennary N-linked glycan chains on Ig domain V of NCAM
(Figure 1C, left panel). First FNIII domain is important for the
polysialylation of NCAM (Close et al., 2003). In SynCAM, which
consists of three extracellular Ig domains, polySia is linked to a
N-linked glycan chain on Ig domain I (Figure 1C, right panel).
Both ST8SIA2 and ST8SIA4 catalyze the transfer of sialic acid
through α2,8-linkages onto sialic acid residues and cooperatively
elongate the polySia chain using CMP-Sia as a donor substrate
(Figure 2A). ST8SIA2 and ST8SIA4, which belong to a family of
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sialyltransferases that are part of the glycosyltransferase family,
are type II membrane proteins that localize in the Golgi appa-
ratus. The protein structure of ST8SIA2 and ST8SIA4 consists of
a short cytoplasmic region connected to a transmembrane (TM)
region that is joined to an intra-luminal region (Figure 2B). The
intra-luminal region consists of a stem region and a catalytic
domain, and sialyl motifs L (Large), S (Small), III, and VS (Very
Short), which are a common feature of α2,3-, α2,6-, and α2,8-
sialyltransferases (Angata and Fukuda, 2003; Takashima, 2008).
Sialyl motif L is positioned in the center of the enzyme and is
characterized by a 55-amino-acid region that serves as a donor
substrate (CMP-Sia) binding site. Sialyl motif S is located at the
C-terminal region of the enzyme and consists of 28 amino acid
residues that are involved in the binding of both donor and accep-
tor substrates. Sialyl motif VS (HXXXXEX) is also located in the
C-terminal region and is reported to be involved in catalytic activ-
ity. Histidine (H) and glutamic acid (E) residues in this motif are
highly conserved between sialyltransferases. Motif III (YHYYD)
is located between sialyl motif S and VS and is also involved
in the catalytic activity of ST8SIA2 and ST8SIA4. In addition, a
novel polybasic polysialyltransferase domain (PSTD; 32 amino
acids) identified next to the motif S in both sialyltransferases
was demonstrated to be involved in the polysialylation activity of
ST8SIA4 (Nakata et al., 2006). More recently, a second conserved
polybasic motif, named polybasic region (PBR), was identified
close to sialyl motif L in ST8SIA2 and ST8SIA4 (Foley et al.,
2009). The PBR consists of 35 amino acids, of which seven are the
basic amino acids arginine (R) and lysine (K), and is involved in
NCAM-specific polysialylation. These basic amino acids are con-
sidered to be important for IgV specific polysialylation of NCAM
through binding via acidic patch of first FNIII domain.
The human ST8SIA2 gene is located on chromosome 15
(Angata et al., 1997) and the corresponding enzyme consists
of six exons (Takashima, 2008). Although the promoter
region of the ST8SIA2 gene has not been well examined
in vitro, the schizophrenia-associated haplotype block of ST8SIA2
appears to localize in the putative promoter region based on
database searches (TFSEARCH, http://mbs.cbrc.jp/research/db/
TFSEARCHJ.html), which identified several putative consensus
motifs and transcriptional factor binding sites, including those for
CCAAT, MZF1, CREB, GATA, TATA, and SP1 (Arai et al., 2006).
In the mouse genome, ST8SIA2 expression is driven by SP1-
binding motifs present in a TATA-less GC-rich domain (Yoshida
et al., 1996) and by the cAMP-CREB cascade (Nakagawa et al.,
2002). It is also reported that ST8SIA2 is under the control of
Pax3 (Mayanil et al., 2000, 2001), a member of a paired homeobox
FIGURE 2 | Biosynthesis of polySia and schematic structure of ST8SIA2.
(A) Mono and di/oligo/polysialylation pathway on the terminal Gal residue of
N-glycan chains. Asialo-glycoprotein is mono-sialylated by the action of
ST3/6GAL. ST8SIA2, ST8SIA4, and/or ST8SIA2/4 can synthesize polySia
chains on the monosialyl residue, particularly on NCAM. (B) Schematic
representation of the protein structure of ST8SIA2. ST8SIA2 consists of a
short cytoplasmic region (CR) connected to a transmembrane (TM) region,
which is followed by an intraluminal region consisting of a stem region and
catalytic domain. In the catalytic domain, SML (Sialyl Motif Large), SMS
(Small), motif III, and SMVS (Very Short) are present. Two additional regions
have been newly characterized: a polybasic polysialyltransferase domain
(PSTD) and a polybasic motif named the polybasic region (PBR). C, cysteine
residues; diamonds, N-glycosylation site; open diamonds, autopolysialylation
sites (Asn 89, 219, and 234) of sixN-linked glycans; arrowheads, exon junction.
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family of evolutionary conserved transcription factors that are
important for brain development.
PHENOTYPES OF polySia-IMPAIRED MICE
To understand the function of polySia, a NCAM-deficient mouse
line was established (Cremer et al., 1994), because NCAM is the
major carrier of polySia in the brain. Based on the observed
phenotype of NCAM knockout (KO) mice, polySia-NCAM was
shown to be required for cell migration, neuronal path find-
ing, and synaptic plasticity necessary for memory formation.
As polySia-NCAM is highly expressed in suprachiasmatic nuclei
(SCN), the effect of polySia on SCN-mediated circadian clock
function was analyzed in adult mice. The removal of polySia
from SCN by the microinjection of endoneuraminidase (endo-
N; polySia specific endo-sialidase) shortened the free-running
period to a similar extent as in the NCAM KO mutant, demon-
strating that NCAM and polySia are involved in the development
and physiology of the mammalian SCN circadian clock (Shen
et al., 1997). NCAM-KO mice also exhibit increased anxiety,
which is thought to be due to altered serotoninergic transmission
(Stork et al., 1999).
To investigate the function of polySia in more detail, ST8SIA2
single KO (SKO) (Angata et al., 2004) and ST8SIA4 SKO mice
(Eckhardt et al., 2000) were established. ST8SIA2 SKO mice
exhibit misguided infrapyramidal mossy fibers and form ectopic
synapses in the hippocampus. Quantification of the myeli-
nated axons in ST8SIA2 SKO mice revealed the number and
size of regenerated fibers are significantly decreased, although
remyelination is not impaired. In addition, ST8SIA2 SKO mice
also exhibit higher exploratory drive and reduced behavioral
responses to Pavlovian fear conditioning. The phenotype of
ST8SIA4 SKO mice was characterized by a marked decrease of
polySia in the CA1 region of Ammon’s horn, indicating that
ST8SIA4 is involved in hippocampal synaptic plasticity, partic-
ularly in long-term potentiation (LTP) and long-term depres-
sion (LTD) in the hippocampal CA1 region. Interestingly, both
ST8SIA2 and ST8SIA4 SKO mice show a profound impairment
in social behavior (Calandreau et al., 2010), including decreased
motivation to interact socially. ST8SIA2 SKO mice exhibit a
behavioral profile that combines increased aggressive behavior
and hyperactivity with reduced anxiety-like behavior, which is
similar to certain attention-deficit hyperactivity disorder-related
pathologies. In contrast, ST8SIA4 SKO mice are predominantly
characterized by decreased motivation in social interaction. This
behavior is the result of olfactory deficits and is associated with a
clear decrease in polySia-NCAM expression in all brain regions.
Recently, precise observations of the polySia-NCAM expression
with adult SKO mice especially in cerebral cortex were reported.
The facts that ST8SIA4 is a responsible for polySia expression in
mature interneurons and in most regions of cortical neuropili
and that ST8SIA2 is the main polysialyltransferase in immature
neurons of the paleocortex layer II and the hippocampal sub-
granular zone (Nacher et al., 2010) are important information to
understand biological meaning of polysialyltransferases.
As polySia can be biosynthesized by either one of the two
polysialyltransferases, SKO mice still contain a large amount of
residual polySia in the brain (Oltmann-Norden et al., 2008).
Thus, to completely remove the background levels polySia,
ST8SIA2, and ST8SIA4 double KO (DKO) mice were established
(Weinhold et al., 2005). DKO mice show a severe phenotype,
characterized by postnatal growth retardation, precocious death,
high incidence of hydrocephalus and agenesis, and hypoplasia of
major brain fiber tracts. Because almost all DKO mice die soon
after birth (80% die before the age of 4 weeks), it appears that the
presence of polySia on not only NCAM, but also other polySia-
containing glycoproteins, plays a direct and important role in
both brain and other unknown tissue functions. Interestingly, in
NCAM, ST8SIA2, and ST8SIA4 triple-KO (TKO)mice, the severe
phenotype of the DKOmice is rescued, suggesting that an uncon-
trolled type of NCAM-mediated cell adhesion is followed by
increased signal transduction events. In TKOmice, improved sig-
naling via increased cell-cell interactions in the polySia-deficient
brain is likely to result from the reduced levels of cell adhe-
sion molecules resulting from the NCAM deficiency. Thus, the
reduction of NCAM leads to the recovery of normal physiolog-
ical interactions and to the rescue of the severe phenotype of
polySia-DKOmice (Hildebrandt et al., 2007).
KNOWN FUNCTIONS OF polySia
It is well known that polySia is involved in numerous important
neurological functions, including neural outgrowth, cell migra-
tion, axonal guidance, and branching, neuronal pathfinding,
lamination of mossy fibers, LTP, and LTD in the hippocam-
pus, synapse formation, and plasticity. The expression of polySia
is spatio-temporally regulated and intimately influences neuro-
genesis and neural circuit development. Thus, the anomalous
expression of polySia impairs learning, memory, behavior (fear
and social behavior), and circadian clock rhythm. There are sev-
eral excellent reviews on the role of polySia in different aspects
of neural development, plasticity, and repair (Bonfanti, 2006;
Gascon et al., 2007; Hildebrandt et al., 2007; Rutishauser, 2008).
Although the underlying mechanisms for how aberrant expres-
sion of polySia leads to these phenotypic abnormalities remain
to be elucidated, several properties, and functions of polySia may
shed light on this issue.
REGULATOR OF CELL ADHESION
The function of polySia as a regulator of cell adhesion has been
well studied in relation to NCAM. NCAM mediates not only
homophilic binding, but also the heterophilic binding of other
CAMs, receptors, and ECMs, including L1, Tag-1, FGF-receptor
(FGFR), GFR1, collagen, HSPG, and CSPG (Gascon et al., 2007).
The binding of these counterpart molecules by NCAM affects
many downstream signaling pathways, including those that reg-
ulate neurite outgrowth, cell migration, fasciculation, axonal
guidance and branching, and synaptogenesis. As polySia contains
extremely large exclusion volumes due to its bulky polyanionic
nature, polySia modification physically inhibits the homophilic
binding of NCAM. Moreover, polySia-NCAM increases the inter-
cellular space between cells, thereby inhibiting cell-cell interac-
tions by hampering the binding between other cell adhesion
molecules, as well as the docking between ligands and receptors
on cell surfaces (Rutishauser, 2008). In addition to inhibiting
trans-interactions, the polysialylation of NCAM may also inhibit
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cis-interactions with other NCAM-associated molecules on the
same membrane (Gascon et al., 2007). Together, the inhibitory
effects of polySia on cell adhesion are termed the “anti-adhesive
effect” (Figure 3A). In addition, polySia can function as an insu-
lating molecule because it displays the repulsive field due to the
large exclusion volume.
As described above, polySia-deficient mice (ST8SIA2- and 4-
DKO mice) do not survive past the early stages of development,
whereas NCAM- and polySia-deficient mice (TKOmice) can typ-
ically reach adulthood. PolySia-deficiency may greatly enhance
NCAM-mediated cell adhesion, which is typically suppressed by
polySia during early development, leading to stronger cell adhe-
sion and abnormal signaling. In TKO mice, the anomalous cell
adhesion found in polySia-deficient DKOmice is compensated by
marked reductions in cell adhesion and signal transduction due to
the deficiency in NCAM. Therefore, polySia is thought to regulate
cell signaling events by influencing the strength of cell adhesion
(Hildebrandt et al., 2007, 2009).
To date, 27 isoforms of NCAM generated by RNA splic-
ing have been identified, among which four major isoforms,
NCAM-180, -140, -120, and sNCAM (soluble NCAM), have
been characterized. NCAM-180 is the major NCAM isoform
involved in the transmission of signals into cells. Among the
known molecules that interact with NCAM, spectrin, Fyn, and
FAK bind to the cytosolic region of NCAM-180, which contains
a palmitoylation and two phosphorylation sites, while NCAM
interaction with spectrin, and PKCβ2 leads to neurite outgrowth.
Homophilic interactions between non-polySia-NCAMs acceler-
ate FAK phosphorylation, recruits adaptor proteins such as Grb2,
Cas, and Shc, and leads to activation of the MAP kinase path-
way through Ras and Raf. In addition, non-polySia-NCAMs
interact heterophilically through their extracellular domains with
other CAMs (L1 and TAG1), proteoglycan (HSPG, CSPG), and
FGFRs as described above. Through these heterophilic interac-
tions, signal transduction events are not only directly regulated by
NCAM, but are also indirectly regulated via other CAMs and/or
growth factor receptors. All of these cell signal pathways are thus
influenced by polysialylation of NCAM.
REGULATION OF ION CHANNELS
Several reports have investigated the relationship between
polySia and memory. For example, NCAM-KO and ST8SIA4-
KO mice have impaired memory, as described above and
studies on the synaptic functions through glutamate recep-
tors have been examined. The results of in-vitro studies
demonstrate that polySia on NCAM modulates the activity
FIGURE 3 | Functions of polySia. (A) Anti-adhesive effect. PolySia-NCAM
imparts a repulsive field on the cell surface due to the large volume of
polySia (shown in gray) to negatively regulate cell-cell interactions. (B)
Regulation of ion transport. The influx and efflux of ions, such as Ca2+
are regulated by polySia. PolySia on NCAM interacts with Ca2+ channels,
such as AMPA receptors, and regulates their opening and closing, by
which polySia controls ion transport. (C) Retention or reservoir of
biologically active molecules. PolySia on NCAM directly binds to various
types of biologically active molecules involved in neural function, such as
neurotrophins, neurotransmitters, and growth factors. PolySia-NCAM
provides attractive fields that regulate their extracellular concentrations
and signaling modes.
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of the α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
(AMPA) receptors (AMPA-Rs) in immature pyramidal neurons
isolated from the CA1 region of the hippocampus (Vaithianathan
et al., 2004). Specifically, polySia prolongs the open channel
time of AMPA-R-mediated currents and alters the bursting pat-
tern of the receptor channels, although polySia does not mod-
ify AMPA-R single-channel conductance (Vaithianathan et al.,
2004). In this case, polySia likely directly interacts with AMPA-R
(Figure 3B). In addition, there are several reports on the rela-
tionship between polySia and N-methyl-D-aspartate (NMDA)
receptors. Impaired CA1 LTP in hippocampal slices is rescued
by the addition of polySia or polySia-NCAM but not NCAM
alone (Senkov et al., 2006), and polySia alone or polySia-NCAM
inhibits the activation of GluN2B-containing NMDA-Rs by low
micromolar concentrations of glutamate (Hammond et al., 2006).
PolySia reduces the open probability, but not the conductance,
of NR2B-containing NMDA-Rs in a polySia- and glutamate
concentration-dependent manner by inhibiting NR2B subunit-
containing NMDA-Rs through Ras-GRF1-p38 MAPK signaling
cascade that is deeply involved in LTP. These findings suggest that
polySia-NCAM is involved in synaptic function in the hippocam-
pus, where it regulates different types of channels in a specific
manner.
Interestingly, a unique α2,9-linked polySia structure, which
was identified on the surface of sperm cells of sea urchin (Miyata
et al., 2006), is involved in sperm motility through the regulation
of intracellular calcium (Ca2+) concentrations. The regulation
seems to be dependent on the binding of α2,9-linked polySia
with of Ca2+transporters, suNCKX (K+-dependent Na+/Ca2+
exchanger), and suPMCA (Ca2+ ATPase), which are involved in
regulating the influx and efflux of Ca2+ in sperm. Consistent with
this finding, the polySia epitope has also been demonstrated to
regulate sperm motility (Kambara et al., 2011). In addition to
the regulation of Ca2+ channels, it is notable that polySia has the
ability to restore Ca2+ ions (Shimoda et al., 1994).
REGULATOR OF NEUROLOGICALLY ACTIVE MOLECULES
Recently, polySia has been shown to directly bind and regu-
late the function of a number of soluble bioactive factors (Sato,
2013). Thus, polySia appears to retain and regulate the function of
specific bioactive factors involved in neural function in the inter-
cellular spaces, and clearly indicates that polySia is involved in not
only neurogenesis, but also in the regulation of neural function.
In this case, polySia has an attractive field toward these bioactive
molecules (Figure 3C). Notably, the bioactive molecules that bind
to polySia have been well characterized in relation to schizophre-
nia and other psychiatric disorders. This novel function of polySia
completely differs from its anti-adhesive effect on cell-cell and
cell-extracellular matrix interactions that is mediated by its bulky
nature and large exclusion volume (i.e., repulsive field), and is of
particular importance to the field of the psychiatry.
Neurotrophins—BDNF, NT3, and NGF
Brain-derived neurotrophic factor (BDNF), which is a member
of the neurotrophins, displays 50% homology with nerve growth
factor (NGF) and is most abundant in brain tissue. BDNF pro-
motes the growth and development of immature neurons, and
also enhances the survival and functional maintenance of adult
neurons via binding to a low-affinity receptor, p75NTR, and a
high-affinity receptor, TrkB. This neurotrophic factor also has an
important role in the neural plasticity that is integral to memory
and learning. Notably, the analyses of NCAM-KO mice has also
demonstrated that polySia-NCAM is involved in memory and
learning. For example, the additions of BDNF to hippocampal
slices derived fromNCAM-KOmice rescued the reduction of LTP
resulting from the disappearance of polySia-NCAM, indicating
that polySia-NCAM is involved in signal transduction mediated
by BDNF receptors (Muller et al., 2000).
Biochemically, the direct binding between polySia and BDNF
was first demonstrated using gel filtration, horizontal native-
PAGE, and surface plasmon resonance (SPR) methods (Kanato
et al., 2008). These solid-based approaches were the first to
demonstrate that BDNF dimers directly bind to polySia and that
the minimum DP required for this interaction is 12 or greater.
The resulting complex between polySia and BDNF is extremely
large (approximately 2500 kDa) was shown to consist of 14 mol
BDNF dimer molecules and 28mol polySia (mean DP = 43)
based on titration and gel filtration experiments. The binding of
polySia is also observed with the neurotrophins NT-3 and NGF
most likely through C-terminal basic regions. BDNF and polySia
do not form ternary complexes with BDNF receptors and BDNF
easily migrate toward receptors after forming a complex with
polySia. The migration can be explained by the affinities of BDNF
toward polySia and BDNF receptors (Figure 4, left panel). The
KD of BDNF toward polySia, as calculated by SPR, is approxi-
mately 10−9 M (Sato et al., 2010; Hane et al., 2012). In contrast,
the KD of BDNF toward TrkB and p75NTR is 10−12 and 10−10 M,
respectively. Based on these results, BDNF in BDNF-polySia
complexes would move toward BDNF receptors because BDNF
has one to three orders of magnitude stronger affinity toward
BDNF receptors than toward polySia. PolySia and polySia-BDNF
complexes were also shown to increase the proliferation of neu-
roblastoma cells compared to untreated control cells. Recently,
evidence was presented to show that ProBDNF processed outside
the cell by tPA/plasmin is important for memory in the hip-
pocampus (Pang et al., 2004). In this context, it is also important
to consider the reservoir function of polySia, because proBDNF
and BDNF, but not the pro-domain, are capable of binding to
polySia (Sato, unpublished results). Taken together, the findings
from these studies demonstrate that polySia is involved in sev-
eral neurotrophin-mediated biological functions, including cell
growth, neurogenesis, and memory.
Neurotransmitters—catecholamines
The specific binding between polySia and catecholamine neu-
rotransmitters, particularly DA, has been demonstrated by
the frontal affinity chromatography (FAC) analyses of numer-
ous factors, including histamine, acetylcholine, serotonin, cat-
echolamines (DA, epinephrine, and norepinephrine), and their
precursors. As the binding is not observed with disialic acid
(DP = 2), catecholamine binding appears specific to polySia,
and it is speculated that these interactions occur between spe-
cific structures of polySia and the catechol backbone (Isomura
et al., 2011). As the KD of DA toward polySia changes depending
Frontiers in Cellular Neuroscience www.frontiersin.org May 2013 | Volume 7 | Article 61 | 6
Sato and Kitajima PolySia, ST8SIA2, and schizophrenia
FIGURE 4 | Proposed mechanism for the retention and release of
biologically active molecules by polySia. Middle panel, PolySia
captures biologically active molecules by direct binding. The retained
molecules are released by one of several ways, as shown in the left
and right panels. Left panel, Specific receptor-mediated release
mechanism-1 (Affinity). In this example, brain-derived neurotrophic factor
(BDNF) in a complex with polySia migrates to the BDNF receptors, TrkB
or p75NTR, based on differences in the affinity between BDNF, the
receptors, and polySia. Right panel, Specific receptor-mediated release
mechanism-1 (Co-receptor). In the case of fibroblast growth factor 2
(FGF2), polySia does not release FGF2 from the FGF2-polySia complex
to the FGF receptor (FGFR). Notably, FGF2 in the FGF2-polySia complex
can migrate to heparan sulfate (HS) to form a FGF2-HS complex, which
can then bind to FGFR as a ternary complex to enhance FGF signaling.
Therefore, polySia regulates FGF2 signaling by passing FGF2 to HS and
finally to FGFR.
on the pH of the solution, the specific interaction between these
molecules might be fine-tuned by subtle changes of the extracel-
lular pH (Sato et al., 2010).
PolySia is also involved in Akt signaling in human neuroblas-
toma cells via DRD2 (Isomura et al., 2011). It is also reported
that polySia is required for DRD2-mediated plasticity involving
inhibitory circuits of the rat medial prefrontal cortex (Castillo-
Gómez et al., 2011). Together, these results suggest that the
polySia-NCAM localized on postsynaptic membranes directly
interacts with catecholamine neurotransmitters, representing a
novel function of polySia.
Growth factors—FGF2
FGF2 is a prototypical member of the FGF family that stimulates
the growth of various cell types, from fibroblasts to tumor cells,
and was first identified in the bovine pituitary gland as a factor
with the potential to induce fibroblast cell proliferation. FGF2
is highly expressed in the brain during earlier stages of devel-
opment, and is involved in brain formation. As recent studies
have demonstrated that FGF2 is a potent modulator of prolifer-
ation and differentiation of multi-potent neural progenitor cells
isolated from the adult SVZ, FGF2 also plays a pivotal role in
adult neurogenesis (Mudò et al., 2009). Due to its importance
in both brain development and function, it is not surprising that
FGF2 has been implicated in a number of psychiatric disorders
(Fumagalli et al., 2005; Gaughran et al., 2006; Turner et al., 2008,
2009; Perez et al., 2009; Graham and Richardson, 2010).
FGF2-FGFR signals are enhanced following the formation
of ternary complexes with heparan sulfate (HS) on HSPG,
which is a component of the ECM. However, the relation-
ship between polySia and FGF2 was not identified until several
recent biochemical analyses, including gel shift assays, gel fil-
tration, and SPR, revealed that polySia binds to FGF2 directly
(Ono et al., 2012). FGF2 monomers bind to polySia and form
a large complex that does not migrate toward FGFR, even if
the receptors are located next to the complex. The KD of FGF2
toward polySia (1.47 × 10−8 M) is smaller than that toward HS
(2.81 × 10−8 M). Consistent with these differences in affinity,
FGF2-polySia and FGF2-HS complexes display unique physical
and biochemical properties. For example, FGF2-polySia binds
to HS- or polySia-coated surfaces, whereas HS-polySia cannot
bind to either of these surfaces, indicating that the binding
regions of FGF2 to polySia and HS differ. In addition, FGF2
complexed with polySia cannot migrate toward FGFRs, but do
migrate toward HS (Figure 4, right panel). It is also demon-
strated that Erk and Akt signaling is regulated by polySia and
HS in polySia- and HS-expressing cells, respectively (Ono et al.,
2012).
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PolySia AND SCHIZOPHRENIA
Schizophrenia is a psychiatric disorder with a complex pathophys-
iology that is influenced by multiple factors. It is also considered
that schizophrenia is deeply related to both neurodevelopmen-
tal and neurodegenerative disorders involving disconnectivity and
disorder of synapses. Indeed, there are several hypotheses such as
glutamate hypothesis, DA hypothesis, and neurodevelopmental
hypothesis (Coyle et al., 2012). Thus, several factors are mutually
involved in pathophysiology of schizophrenia in a complicated
manner, which makes it difficult to understand the underly-
ing mechanism of schizophrenia clearly. Among the factors,
polySia might be an important molecule for understanding this
disorder.
Recently, indirect evidence has been reported that suggests
that polySia is involved in schizophrenia. For example, it was
first reported that the degree of immunostaining for polySia-
NCAM derived from the hippocampus of schizophrenic brains
is decreased compared with that of normal brains (Barbeau
et al., 1995). In addition, chromosome 15q26, which is the
genomic region containing the gene encoding ST8SIA2, is related
to schizophrenia and bipolar disorders among the population
of Eastern Quebec (Maziade et al., 2005). Recently, a relation-
ship between SNPs in the promoter region of the ST8SIA2
gene and schizophrenia was identified by genome-wide associ-
ation studies in the Japanese (Arai et al., 2006) and Chinese
Han populations (Tao et al., 2007). The ST8SIA2 gene is also
reported to be a generalized susceptibility marker for psychotic
and mood disorders on chromosome 15q25-26 (McAuley et al.,
2012), and is associated with an increased risk of mental ill-
ness, such as autism (Anney et al., 2010). Interestingly, the
mutation of synCAM, which is another substrate for ST8SIA2,
is also related with autism spectrum disorders (Zhiling et al.,
2008).
As described above, to determine the relationship between
genes and phenotypes, it is necessary to biochemically character-
ize the target gene product, particularly if it is an enzyme, because
the enzymatic reaction product has a biological role. In this con-
text, the in-vitro and in-vivo enzymatic activity of ST8SIA2 (SNP-
7; Glu141Lys) that was reported from a schizophrenic patient
was measured and was shown to be markedly decreased under
both conditions (Isomura et al., 2011). The mutated amino acid
is localized near sialyl motif L that has clearly been shown to
be required for the enzymatic activity of ST8SIA2. In addition,
the amount and quality (DP) of the produced polySia were also
impaired (Hane et al., 2012), a result that is consistent with the
histochemical data, although it only represents a change in the
amount of polySia. Because the polySia structure biosynthesized
by the SNP-7 of ST8SIA2 was impaired compared with that by
normal ST8SIA2, the bindings toward BDNF, FGF2, and DA were
also impaired (Isomura et al., 2011; Hane et al., 2012). BDNF,
FGF2, and DA are known to be key molecules for the causes
and biomarker of schizophrenia (Terwisscha van Scheltinga et al.,
2010; Buckley et al., 2011; Balaratnasingam and Janca, 2012;
Eyles et al., 2012; Tritsch and Sabatini, 2012). Impairment of
the new function of polySia as a regulator of neurological active
molecules will thus lead to pathophysiology of schizophrenia.
Especially, behavioral deficits in psychiatric disorders have been
hypothesized to arise from the elevations in the cellular balance
of excitation and inhibition within neural microcircuitry (Yizhar
et al., 2011). Therefore, the impact on the glycocalyx such as
polySia located in the region that generates neural microcircuitry
might be important. Taken together, these results suggest that
FIGURE 5 | Disease risk depends on the quantity and quality of polySia.
The quantity and quality (degree of polymerization) of polySia may differ from
person to person, particularly for patients suffering from psychiatric disorders
or other neurodegenerative diseases. Direct and indirect lines of evidence
show that quantity and quality of polySia on NCAM are critically important for
normal brain functions. Hyper- or hypo-polysialylation of NCAM might lead to
the impairment of brain function through the stimulation or repression of
dopamine-, BDNF- and FGF2-mediated signaling.
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changes in the quantity and quality, particularly DP, of
polySia, which are closely related with the enzymatic activ-
ity of ST8SIA2, lead to an altered binding affinities toward
BDNF, FGF2, and DA, may be one of the underlying causes of
schizophrenia.
Anatomically, the volume of olfactory bulbs derived from
schizophrenic brains is reduced (Turetsky et al., 2003), which is
a similar phenotype to that of NCAM-KO mice (Cremer et al.,
1994). The functional impairment and disturbed organization of
the hippocampus are also involved in the etiology of schizophre-
nia (Harrison, 2004). In addition, a reduction of polySia-NCAM
in dorsolateral prefrontal cortex of schizophrenic patients was
reported (Gilabert-Juan et al., 2012). In this aspect, it is interest-
ing that loss of ST8SIA2 or NCAM resulted in the misguidance
of infrapyramidal mossy fibers and the formation of ectopic
synapses in the hippocampus (Angata et al., 2004). In addition,
several characteristic properties, such as brain structure, neural
plasticity, and various morphological, cognitive, and emotional
deficits related to schizophrenia have been observed in ST8SIA2-
or ST8SIA4-SKOmice (Hildebrandt et al., 2007; Calandreau et al.,
2010). Very recently, NCAM-KO mice were demonstrated that
they are useful for studying specific endophenotypes with rele-
vance to the schizophrenia although they do not display a typical
schizophrenia-like phenotypes (Albrecht and Stork, 2012). As
NCAM is not the only substrate for ST8SIA2 and the underlying
biosynthetic mechanisms of polySia by ST8SIA2 and ST8SIA4 are
not well understood, it is important to focus on the contribution
of glycoepitopes, such as polySia, to schizophrenia.
CONCLUSION
As psychiatric disorders such as schizophrenia are complex dis-
eases with multiple factors contributing to pathogenesis, the
mechanisms by which polySia is involved in these disorders are
also likely complex. However, it is clear that the quality and
quantity of polySia-NCAM are strictly regulated in normal cells,
and that the impairment of polySia has profound effects on
various brain functions through increasing cell adhesion, modi-
fying ion channel activity, and reducing binding affinity toward
biologically active molecules. Such impairments might lead to
psychiatric disorders or affect the prognosis of these diseases
(Figure 5). Interestingly, imbalances in the quantity of polySia-
NCAM are also found in patients suffering from Alzheimer’s
disease (Mikkonen et al., 1999), Parkinson’s disease (Oizumi et al.,
2008), and drug abuse (Murphy et al., 2006). As demonstrated
by the study of polySia, exploring the structure and function of
unique glycocalyx components on the cell surface is expected to
give further insight into psychiatric diseases because the glycoca-
lyx is a major, but often ignored, player for the communication
between cells and the extracellular environment.
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